NASDAQ:NMRD

Nemaura Medical Stock Insider Trading

Healthcare > Medical - Devices

Buy NMRD

*Your capital is at risk

$0.0002

+0 (+0%)

At Close: Jun 03, 2026

Nemaura Medical Stock Insider Power

Based on the 62 latest insides trades, we have calculated the insider power to be negative at 0. In total, the insiders bought 275.25M and sold 274.75B NMRD shares in the last 62 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power (Last 62 transactions)	0
● Buy	275.25M shares
● Sell	274.75B shares
81% Buy Activity Negligible or No Correlation
No Significant Signals No statistically significant buy or sell signals detected in recent insider data.

Historical Insider Trades

Date	Type	Person	Role	Amount
Jun 05, 2018 Buy	Common Stock J-Other	Timol Bashir Chief Business Officer	Officer	27 082 000 Value: $0
Jun 05, 2018 Sell	Series A Convertible Preferred Stock C-Conversion	Timol Bashir Chief Business Officer	Officer	27 082 Value: $0
Jun 05, 2018 Buy	Common Stock J-Other	Chowdhury Dewan Fazlul Hoque Chief Executive Officer	CEO / President	87 537 000 Value: $0
Jun 05, 2018 Sell	Series A Convertible Preferred Stock C-Conversion	Ismail Sufyan 10 Percent Owner	10% Owner	22 705 Value: $0
Jun 05, 2018 Buy	Common Stock J-Other	Ismail Sufyan 10 Percent Owner	10% Owner	22 705 000 Value: $0
Nov 06, 2017 Buy	Series A Convertible Preferred Stock J-Other	Chowdhury Dewan Fazlul Hoque Chief Executive Officer	CEO / President	87 537 Value: $0
Nov 06, 2017 Sell	Common Stock J-Other	Ismail Sufyan 10 Percent Owner	10% Owner	22 705 000 Value: $0
Nov 06, 2017 Buy	Series A Convertible Preferred Stock J-Other	Ismail Sufyan 10 Percent Owner	10% Owner	22 705 Value: $0
Nov 06, 2017 Sell	Common Stock J-Other	Chowdhury Dewan Fazlul Hoque Chief Executive Officer	CEO / President	87 537 000 Value: $0
Nov 06, 2017 Sell	Common Stock J-Other	Timol Bashir Chief Business Officer	Officer	27 082 000 Value: $0
Nov 06, 2017 Buy	Series A Convertible Preferred Stock J-Other	Timol Bashir Chief Business Officer	Officer	27 082 Value: $0
Nov 06, 2017 Buy	Series A Convertible Preferred Stock J-Other	Timol Bashir Chief Business Officer	Officer	27 082 Value: $0
Nov 06, 2017 Sell	Common Stock J-Other	Timol Bashir Chief Business Officer	Officer	27 082 000 Value: $0
Nov 06, 2017 Buy	Series A Convertible Preferred Stock J-Other	Ismail Sufyan 10 Percent Owner	10% Owner	22 705 Value: $0
Nov 06, 2017 Sell	Common Stock J-Other	Ismail Sufyan 10 Percent Owner	10% Owner	22 705 000 Value: $0
Nov 06, 2017 Buy	Series A Convertible Preferred Stock J-Other	Chowdhury Dewan Fazlul Hoque Chief Executive Officer	CEO / President	87 537 Value: $0
Nov 06, 2017 Sell	Common Stock J-Other	Chowdhury Dewan Fazlul Hoque Chief Executive Officer	CEO / President	87 537 000 Value: $0
Aug 03, 2017 Buy	Common Stock J-Other	Moore Thomas Peter	Director	0 Value: $0
Aug 03, 2017 Buy	Common Stock J-Other	Moore Thomas Peter	Director	0 Value: $0
Jul 26, 2017 Buy	Common Stock	Natha Salim Director	Director	0 Value: $0
Jul 26, 2017 Buy	Common Stock	Natha Salim Director	Director	0 Value: $0
Jul 17, 2017 Buy	Common Stock J-Other	Johnson Timothy Christopher	Director	0 Value: $0
Jul 17, 2017 Buy	Common Stock J-Other	Johnson Timothy Christopher	Director	0 Value: $0
Jan 12, 2016 Buy	Common Stock J-Other	Anderson Iain Officer	Officer	0 Value: $0
Jan 12, 2016 Buy	Common Stock J-Other	Anderson Iain Officer	Officer	0 Value: $0

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%^* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

ABOUT NEMAURA MEDICAL INC.

Nemaura Medical Inc., a medical technology company, discovers, develops, and commercializes diagnostic medical devices. It provides sugarBEAT, a non-invasive continuous glucose monitoring device for use by persons with Type I and Type II diabetes, as well as screen pre-diabetic patients. The company also offers proBEAT, a wellness guidance notes, that provide prompts and educate users on factors affecting blood sugar profiles, as well as conducts...

Read Full Profile Here